4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-029901
Chief Executive Officer gave up 18,948 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-05-15 | Shares withheld for taxes | −18,948 | $0.82 | $15,537 | 3,995,309 | D |
Loading xslF345X03/doc4.xml…